Words Matter: Decreasing Stigma While Caring For Pregnant People with Substance Use-Overview of the MAT and MATE Act Changes

Overview of the MAT and MATE Act Changes

Pdf Summary

Starting from December 29, 2022, the DATA 2000 waiver is no longer necessary to prescribe buprenorphine for opioid use disorder. Only a DEA number is required. The MACS team of addiction medicine experts is available to assist healthcare teams with providing this life-saving treatment. Healthcare providers and their teams can access MACS technical assistance to implement or expand office-based treatment for opioid use disorder, including buprenorphine. Contact MACS at 1-855-337-MACS for support with best practices for office-based prescribing, workflow development, practice protocols, customized trainings, and other services. Help spread the word by sharing this information and the MACS website with your healthcare provider colleagues. For more details on the legislative updates and how MACS can support you, visit www.marylandmacs.org or contact macs@som.umaryland.edu.

Keywords

DATA 2000 waiver

buprenorphine

opioid use disorder

DEA number

MACS team

addiction medicine experts

healthcare teams

office-based treatment

best practices

legislative updates